Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.40 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.34 |
| ▸ | GABRP | O00591 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2448267 | 1.00 | GSR (0.41) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL28335157 | 0.78 | GSR (0.44) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL29198588 | 0.77 | FOLH1 (0.41) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL451173 | 0.75 | GSR (0.39) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL19100559 | 0.75 | GSR (0.39) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL451174 | 0.75 | GSR (0.39) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL43620 | 0.74 | FOLH1 (0.57) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL50111 | 0.74 | FOLH1 (0.57) | GSRRNPEPFOLH1CYP2D6NFKB1 | |
| SCHEMBL1328597 | 0.73 | SIRT6 (0.44) | GSRRNPEPFOLH1CPB2GNAI3 | |
| SCHEMBL380767 | 0.73 | FOLH1 (0.56) | GSRRNPEPFOLH1CYP2D6NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9932687-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2018-04-03 | — | — | US | disclosed |
| US-20160184824-A1 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-06-30 | — | — | US | disclosed |
| US-9205423-B2 | High throughput screening of crystallization of materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2015-12-08 | — | — | US | disclosed |
| US-8709153-B2 | Microfludic protein crystallography techniques | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-04-29 | — | — | US | disclosed |
| US-20140041727-A1 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-02-13 | — | — | US | disclosed |
| US-8518883-B2 | Method of reducing deleterious effects of ischemia by administration of a thrombopoietin receptor ligand | MCW RESEARCH FOUNDATION, INC. (US) | 2013-08-27 | — | — | US | disclosed |
| EP-1392484-B1 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | CALIFORNIA INST OF TECHN (US) | 2013-06-12 | — | — | EP | disclosed |
| US-8382896-B2 | High throughput screening of crystallization materials | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2013-02-26 | — | — | US | disclosed |
| US-20120241015-A1 | Microfluidic Protein Crystallography Techniques | NATIONAL INSTITUTES OF HEALTH | 2012-09-27 | — | — | US | disclosed |
| US-20110306522-A1 | MICROFLUIDIC PROTEIN CRYSTALLOGRAPHY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2011-12-15 | — | — | US | disclosed |
| US-20050062196-A1 | Microfluidic protein crystallography techniques | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2005-03-24 | — | — | US | disclosed |
| US-20050019794-A1 | Crystal growth devices and systems, and methods for using same | FLUIDIGM CORPORATION (US) | 2005-01-27 | — | — | US | disclosed |
| WO-2004104228-A1 | MICROFLUIDIC PROTEIN CRYSTALLOGRAPHY | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2004-12-02 | — | — | WO | disclosed |
| WO-2004094020-A2 | CRYSTAL GROWTH DEVICES AND SYSTEMS, AND METHODS FOR USING SAME | FLUIDIGM CORPORATION (US) | 2004-11-04 | — | — | WO | disclosed |
| US-20040198663-A1 | Method of treating cardiac ischemia by using erythropoietin | POIETIS, LLC | 2004-10-07 | — | — | US | disclosed |
| EP-1392484-A4 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | CALIFORNIA INST OF TECHN (US) | 2004-07-28 | — | — | EP | disclosed |
| US-20040115731-A1 | Microfluidic protein crystallography | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2004-06-17 | — | — | US | disclosed |
| EP-1392484-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS | California Institute of Technology (US) | 2004-03-03 | — | — | EP | disclosed |
| US-20030061687-A1 | High throughput screening of crystallization materials | CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION | 2003-04-03 | — | — | US | disclosed |
| WO-2002082047-A2 | HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2002-10-17 | — | — | WO | disclosed |